CVS Health struck a deal with dissident Glenview Capital, giving the investor four board seats. Glenview had been pushing for changes at the health-care giant and had met with former CEO Karen Lynch prior to her ouster.

CVS Health said on Monday it added four new members to its board including hedge fund Glenview Capital's chief executive Larry Robbins as part of a standstill agreement with the activist investor. Shares of CVS rose 2% to $54.

CVS Health said on Monday it named four new members to its board of directors as part of a deal with activist investor Glenview Capital as the healthcare company continues to fight its way out of its brutal 2024.